Role of Biomarkers of Myocardial Injury to Predict Adverse Outcomes in Hypertrophic Cardiomyopathy
Circulation: Cardiovascular Quality & Outcomes
JANUARY 19, 2024
Circulation: Cardiovascular Quality and Outcomes, Ahead of Print. Background:Serum troponins and CK-MB (creatine kinase-MB) are readily detectable and reliable cardiac-specific biomarkers of subclinical myocardial injury. This study explores the roles of cTnI (cardiac troponin I) and CK-MB in hypertrophic cardiomyopathy (HCM).Methods:This
Let's personalize your content